Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Subgroup Additional Only
C12N 2710/10311

Mastadenovirus, e.g. human or simian adenoviruses

Full Title

dsDNA viruses > Details > Adenoviridae > Mastadenovirus, e.g. human or simian adenoviruses

12 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

  • C12N 2710/10321 Viruses as such, e.g. new isolates, mutants or their genomic sequences
  • C12N 2710/10322 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
  • C12N 2710/10323 Virus like particles [VLP]
  • C12N 2710/10331 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
  • C12N 2710/10332 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
  • C12N 2710/10333 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
  • C12N 2710/10334 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
  • C12N 2710/10371 Demonstrated in vivo effect
  • C12N 2710/10388 for redistribution

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

  1. HARVARD UNIVERSITY US 8,321
  2. CHINESE ACADEMY OF SCIENCES 7,486
  3. UNIVERSITY OF CALIFORNIA US 7,320
  4. REGENERON PHARMACEUTICALS US 5,003
  5. INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
  6. UNIVERSITY OF PENNSYLVANIA US 4,213
  7. CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
  8. JIANGNAN UNIVERSITY 3,961
  9. ROCHE CH 3,792
  10. ILLUMINA US 3,692